Recent research investigated the efficacy and safety of long-term use of pioglitazone in patients with nonalcoholic steatohepatitis and prediabetes or diabetes.
A recent study examined the association between proton pump inhibitors and risk of developing chronic kidney disease, kidney disease progression, and end-stage renal disease.
A new study examined the potential for utilizing the American Heart Association’s Life’s Simple 7 metric, developed to measure and promote cardiovascular health, to help predict risk of chronic kidney...
A multi-center study finds kidney transplantation from HIV-positive donors to HIV-positive recipients is as safe and effective as using kidneys from HIV-negative donors, offering new insights into expanding...
A recent meta-analysis sheds light on the increased burden of cardiovascular complications in this group, emphasizing the importance of early identification and management of modifiable risk factors.
Giving proton pump inhibitors in combination with diuretics can increase the risk of hospitalization for hypomagnesemia, according to Canadian researchers.
